InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by MacKay-Dunn R. Hector, Director. Officer active across 1 companies, notably Aurinia Pharmaceuticals Inc.. Aggregated, 3 reports have been recorded. Total volume traded: €60k. The latest transaction was disclosed on 9 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€50,4535,000 shares@ €10.09060.0024% mcap84.6% of flow
Common Stock
SEC:0001628280-22-005882:0·
Ideal exit: 4 Dec 2022 (T+270)
€4,599500 shares@ €9.1976100.0% of flow
Common Stock
SEC:0001628280-21-010163·
Ideal exit: 5 Feb 2022 (T+270)
€4,599500 shares@ €9.19760.0002% mcap7.7% of flow
Common Stock
SEC:0001628280-21-010163:0·
Ideal exit: 5 Feb 2022 (T+270)
3 of 3 declarations
About MacKay-Dunn R. Hector
Hector R. MacKay-Dunn is a Board Member at Aurinia Pharmaceuticals Inc. He plays an essential role in the governance of the company, overseeing operations and contributing to growth strategy.
